-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Buy on Steris, Lowers Price Target to $270

Benzinga·08/07/2026 23:30:25
Listen to the news
UBS analyst Patrick Wood maintains Steris (NYSE:STE) with a Buy and lowers the price target from $275 to $270.